HCA Healthcare rose 7.3% from $477.10 to $511.78, behind the S&P 500's +11.2%. Its worst day was Apr 24 (−8.8%), and its low came Jun 8 at $361.32.
Story events cover the past 12 months · Times ET
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $8.01 beat the $7.42 estimate on $19.5B revenue (est. $19.7B); FY revenue guidance of $76.5B–$80.0B against the $79.2B consensus.
+7.1% · S&P 500 +0.4%
HCA Healthcare shares rose 5.9%, while the S&P 500 fell 0.0%.
+5.9% · S&P 500 0.0%
HCA Healthcare closed at its highest level of the year, 14.3% above where the year started.
+2.3% · S&P 500 +0.9%
EPS of $7.15 missed the $7.16 estimate on $19.1B revenue (est. $19.1B); FY revenue guidance of $76.5B–$80.0B against the $78.6B consensus.
−8.8%, the year's worst day · S&P 500 +0.8%
HCA Healthcare closed at its lowest level of the year, 24.3% below where the year started.
−2.9% · S&P 500 +0.2%
HCA Healthcare shares fell 6.9%, while the S&P 500 rose 0.4%.
−6.9% · S&P 500 +0.4%
EPS of $7.59 beat the $7.41 estimate on $20.2B revenue (est. $19.4B); FY revenue guidance of $77.0B–$79.5B against the $78.6B consensus.
+1.5% · S&P 500 +0.1%
HCA Healthcare shares rose 5.6%, while the S&P 500 rose 0.4%.
+5.6% · S&P 500 +0.4%
EPS of $7.22 beat the $6.65 estimate on $19.8B revenue (est. $19.3B); FY revenue guidance of $78.3B–$79.5B against the $78.5B consensus.
−3.3% · S&P 500 +0.6%
HCA Healthcare shares rose 10.3%, while the S&P 500 rose 1.7%.
+10.3%, the year's best day · S&P 500 +1.7%
Where it ended: a close of $511.78 on Nov 16, 2026. Up next: Q4 2026 earnings on Jan 26, 2027 (EPS est. $8.18, revenue est. $20.0B).
